In vivo effects of meloxicam, celecoxib, and ibuprofen on free radical metabolism in human erythrocytes

Drug and Chemical Toxicology

Volumn 26, Issue 3, 2003, Pages 169-176

  Cimen, M Y Burak ^a   Cimen, Özlem Bölgen ^a   Eskandari, Gülcin ^a   Sahin, Günşah ^a   Erdoǧan, Canan ^a   Atik, Uǧur ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Erythrocytes; Free radicals; Nonsteroidal anti inflammatory drugs (NSAIDs)

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CATALASE; CELECOXIB; FREE RADICAL; GLUTATHIONE PEROXIDASE; HYDROCORTISONE; IBUPROFEN; MALONALDEHYDE; MELOXICAM; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ERYTHROCYTE METABOLISM; HUMAN; IN VIVO STUDY; INFLAMMATION; OSTEOARTHRITIS;

CATALASE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ERYTHROCYTES; FREE RADICAL SCAVENGERS; GLUTATHIONE PEROXIDASE; HUMANS; IBUPROFEN; ISOENZYMES; MALONDIALDEHYDE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; SULFONAMIDES; SUPEROXIDE DISMUTASE; THIAZINES; THIAZOLES;

FELIS CATUS;

EID: 0042134696     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.1081/DCT-120022645     Document Type: Article

References (20)

1. Roth, G.R.; Majerus, S.W. The mechanism of the effect of aspirin on human platelets. Acetylation of a particular fraction protein. J. Clinical Investigation 1975, 56, 624-632.
2. Richardson, C.; Emery, P. The clinical implications of inhibition of the inducible form of cyclo-oxygenase. Drug Safety 1996, 15 (4), 249-260.
3. Pairet, M.; Churchill, L.; Engelhardt, G. Differential inhibition of cyclooxygenase 1 and 2 by NSAIDs. In New Targets in Inflammation. Inhibition of COX-2 or Adhesion Molecules; Bazan, N., Botting, J., Vane, S.J., Eds.; Kluwer Academic Publishers: New Orleans, 1996; 23-38.
4. Halliwell, B.; Gutteridge, J.M.C. The importance of free radicals and catalytic metal ions in human disease. Molec. Aspects Med. 1985, 8, 135-153.
5. Kirkova, M.; Kassabova, T.; Russanov, E. In vivo effects of indomethacin-I. Activity of antioxidant enzymes and lipid peroxidation. Gen. Pharmac. 1992, 23 (3), 503-507.
6. Weglarz, L.; Drozdz, M.; Goss, M. Effects of anti-inflammatory drugs on the activity of antioxidant enzymes and in vivo peroxidation products in the liver and kidney of rat. Comp. Biohem. Physiol. 1990, 96C (1), 83-85.
7. Maffei, Facino R.; Carini, M.; Aldini, G.; Saibene, L.; Macciocchi, A. Antioxidant profile of nimesulide, indomethacin and diclofenac in phosphatidylcholine liposomes (PCL) as membrane model. Int. J. Tiss. React. 1993, 15 (6), 225-234.
8. American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis and Rheumatism 1990, 34, 505-514.
9. Beutler, E. Glucose 6 phosphate dehydrogenase. In Red Cell Metabolism. A Manual Biochemical Procedure; Grune and Stratton: New York, 1975; 66-69.
10. Aebi, H. Catalase. In Methods of Enzymatic Analysis; Bergmeyer, H.U., Ed.; Academic Press: New York-London, 1974; 673-677.
11. Paglia, D.E.; Valentine, W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70, 158-169.
12. Van Ye, T.M.; Roza, A.M.; Pieper, G.M.; Henderson, J., Jr.; Johnson, C.P.; Adams, M.B. Inhibition of intestinal lipid peroxidation does not minimize morphological damage. J. Surg. Res. 1993, 55, 553-558.
13. Özturk, H.S.; Çimen, M.Y.B.; Çimen, Ö.B.; Kaçmaz, M.; Durak, I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int. 1999, 19, 35-37.
14. Emery, P. Clinical implications of selective cyclooxygenase-2 inhibition. Scand. J. Rheumatol. 1996, 25 (Suppl. 102), 23-28.
15. Kirkova, M.; Kassabova, T.; Russanov, E. In vivo effects of indomethacin-II. Antioxidant enzymes and metal deficient rats. Gen. Pharmac. 1992, 23 (2), 151-154.
16. Durak, I.; Karaayvaz, M.; Çimen, M.Y.B.; Avci, A.; Bölgen Çimen, Ö.; Büyükkoçak, S.; Öztürk, H.S.; Özbek, H.; Kaçmaz, M. Aspirin impairs antioxidant system and causes peroxidation in human erythrocytes and guinea pig myocardial tissue. Human & Experimental Toxicology 2001, 20, 34-37.
17. Maffei Facino, R.; Carini, M.; Aldini, G. Antioxidant activity of nimesulide and its main metabolites. Drugs 1993, 46 (suppl 1), 15-21.
18. Zheng, S.X.; Mouithys-Mickalad, A.; Deby-Dupont, G.P.; Deby, C.M.; Maroulis, A.P.; Labasse, A.H.; Lamy, M.L.; Crilaard, M.R.; Reginster, J.Y.L.; Henrotin, Y.E. In vitro study of the antioxidant properties of nimesulide and 4-OH nimesulide: effects on HRP- and luminol dependent chemiluminescence produced by human chondrocytes. Osteoarthritis and Cartilage 2000, 8, 419-425.
19. Villegas, I.; Martin, M.J.; La Casa, C.; Motilva, V.; Lastra, C.A. Effects of meloxicam on oxygen radical generation in rat gastric mucosa. Inflamm. Res. 2000, 49, 361-366.
20. Pereira, B.; Bechara, E.J.H.; Mendonqa, J.R.; Curi, R. Superoxide dismutase, catalase and glutathione peroxidase activities in the lymphoid organs and skeletal muscle of rats treated with dexamethasone. Cell Biochemistry and Function 1999, 17, 15-19.